Business
Boston Scientific has an exclusive option to buy the mitral valve developer for $200 million.
Hi, what are you looking for?
Boston Scientific has an exclusive option to buy the mitral valve developer for $200 million.
Blackstone Group LP agreed to buy BioMed Realty Trust Inc, a supplier of office space to health care companies, in a deal valued...
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Clal Biotechnology Industries Ltd. reported to the Tel Aviv Stock Exchange Today that its wound and burn care solutions unit MediWound Ltd. has been awarded...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
IBM has selected Israeli Teva Pharmaceutical Industries Ltd. as its first foundational life sciences partner for the Watson Health Cloud. Financial terms of the partnership...
Kyma has developed a remote patient monitoring system for fluid management in patients suffering heart failure.
Stemcentrx, a startup with funding from billionaire tech investor Peter Thiel, just came out of stealth at a $5 billion valuation, the Wall...
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April